Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2024.
Financials
Financial year 2025
PharmGo from Neupré, company number BE0760516127, closed financial year 2025 with a result of € 37,352 after tax. For that financial year PharmGo recorded a gross margin of € 67,824 and equity of € 96,507. Compared with financial year 2024, the result moved from € 28,427 to € 37,352. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 7, 2026.
€ 96,507
▲ 63% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 37,352
▲ 31% vs 2024
Profit after tax over the fiscal year.
€ 45,801
▼ 4% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 94,507.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 2,582
▼ 51% vs 2024
Of which on lease € 2,582.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 4,517
▲ 15% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 5,635
▼ 71% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 34,090 | € 81,729 | € 57,483 | € 67,824 | ▲ 18% |
| Profit after taxes | € 14,252 | € 47,631 | € 28,427 | € 37,352 | ▲ 31% |
| Equity | € 30,156 | € 77,787 | € 59,155 | € 96,507 | ▲ 63% |
| Total debts | € 59,144 | € 42,483 | € 63,313 | € 19,630 | ▼ 69% |
| Cash | € 13,538 | € 30,663 | € 47,636 | € 45,801 | ▼ 4% |
| Retained profit | € 28,156 | € 75,787 | € 57,155 | € 94,507 | ▲ 65% |
| Dividend | € 0 | € 0 | € 47,059 | € 0 | ▼ 100% |
| Balance sheet total | € 89,299 | € 120,270 | € 122,469 | € 116,137 | ▼ 5% |
Key figures of PharmGo, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PharmGo?
What happened at PharmGo in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 37,352 (▲ 31% vs 2024). filed late Source: NBB ↗
- New establishment in Neupré. KBO
- Gaultier Purper became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 14,252 profit in 2022 to € 37,352 profit in 2025.
Paid € 50,009 in corporate taxes since 2022.
Best year ever: 2023, with € 47,631 profit.
Paid out € 47,059 in dividends to the owners in total.
A new publication or filing at PharmGo? We notify you, reason included.
Follow PharmGoDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
Gaultier Purper
Director
since 2020
Establishments
Establishment units
Physical locations of this company
Drève du Bois de Neuville(N) 52
4121 Neupré
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0760.516.127
- VAT number
- BE 0760.516.127
- Registered office
- Drève du Bois de Neuville(N) 52, 4121 Neupré
- Names & denominations
- PharmGo
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 24 December 2020
- Peppol
- Active · Active since 13 Dec 2025
- Activities · NACE
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige gespecialiseerde wetenschappelijke en technische activiteiten
Overige reiniging van gebouwen; industriële reiniging
Overige zakelijke dienstverlening, n.e.g.
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen